Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Cell Reports|June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 DeregulationHyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
The Journal of Clinical Investigation|May 1, 2025
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patientsRamon Staeger, Aizhan Tastanova, Adhideb Ghosh, et al.
Nature Communications|October 10, 2020
The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stressMichael Bauer, Zuzana Nascakova, Anca-Irina Mihai, et al.
Cancer Immunology Research|November 15, 2018
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against MelanomaSabrina A Hogan, Anaïs Courtier, Phil F Cheng, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2024
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage MelanomaKarlijn de Joode, Alfonso Rojas Mora, Ron H N van Schaik, et al.
Med (New York, N.Y.)|April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanomaRamona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Archives of Dermatological Research|October 1, 2024
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and ageIon Birkenmaier, Lara Valeska Maul, Iker Oyanguren, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
The EMBO Journal|May 8, 2024
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversificationRoma Parikh, Shivang Parikh, Daniella Berzin, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Cell Reports|June 2, 2015
Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 DeregulationHyungsoo Kim, Dennie T Frederick, Mitchell P Levesque, et al.
The Journal of Clinical Investigation|May 1, 2025
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T-cells in uveal melanoma patientsRamon Staeger, Aizhan Tastanova, Adhideb Ghosh, et al.
Nature Communications|October 10, 2020
The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stressMichael Bauer, Zuzana Nascakova, Anca-Irina Mihai, et al.
Cancer Immunology Research|November 15, 2018
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against MelanomaSabrina A Hogan, Anaïs Courtier, Phil F Cheng, et al.
The EMBO Journal|July 4, 2019
Proteomic identification of a marker signature for MAPKi resistance in melanomaVerena Paulitschke, Ossia Eichhoff, Christopher Gerner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2024
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage MelanomaKarlijn de Joode, Alfonso Rojas Mora, Ron H N van Schaik, et al.
Med (New York, N.Y.)|April 9, 2024
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanomaRamona Schlenker, Petra C Schwalie, Steffen Dettling, et al.
Archives of Dermatological Research|October 1, 2024
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and ageIon Birkenmaier, Lara Valeska Maul, Iker Oyanguren, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
The EMBO Journal|May 8, 2024
Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversificationRoma Parikh, Shivang Parikh, Daniella Berzin, et al.
Pageof 21